investordatabase.org

Samsara BioCapital, LLC

samsaracap.com Direct investor

Samsara BioCapital is a venture capital firm that invests in biotechnology and therapeutic companies. It focuses on creating transformative therapeutics and partners with scientists and entrepreneurs.

Samsara BioCapital, LLC is a venture capital firm headquartered in Palo Alto, United States, founded in 2017. It invests directly in companies, from Series A to Series C and later, in biotech, therapeutics and life sciences.

“Investing to create transformative therapeutics for patients.”

— Samsara BioCapital, LLC, own website
Layer
Direct investor
Type
Venture capital
Stage
Series A – Series C+
Headquarters
Palo Alto, United States
Invests in
US
Sectors
biotech, therapeutics, life sciences
Founded
2017

Team, as Samsara BioCapital, LLC publishes it

  • Srini Akkaraju Founder & Managing Partner
  • Mike Dybbs Partner
  • Abe Bassan Partner
  • Mitchell Mutz Senior Principal
  • Matt Eckler Principal, Public Investing
  • Jake Bieber-Dishart Senior Associate
  • Clara Dong Senior Associate
  • Ehi Akhirome Senior Associate
  • Jim P. Edwards Venture Partner
  • David Parry Venture Partner
  • Ravi Rao Venture Partner

Names and roles exactly as listed on samsaracap.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 39 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

and 29 more — the graph.

Where this comes from

Every fact above was read from a page Samsara BioCapital, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4916 · added 2026-09-03 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under